Concepedia

Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial

Mathilde Hunault, Malgorzata Truchan-Graczyk, D. Caillot, Jean‐Luc Harousseau, Serge Bologna, Chantal Himberlin, D Guyotat, C. Berthou, P. Casassus, Laurence Baranger,

Haematologica · 2007 · 31 citations · 24 references

DOIFull text

Open access

Abstract

Randomized maintenance or high-dose therapy (HDT) and ASCT or intensified HDT according to initial presentation gave similar overall and relapse-free survival rates. However, HDT allowed sparing of mediastinal irradiation and shortened treatment duration.

References

24

Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults

D. Hoelzer, E. Thiel, H. Löffler et al. · Blood · 1988 · 588 citations · Full text

Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report.

Alfred Reiter, Martin Schrappe, Wolfgang Ludwig et al. · PubMed · 2000 · 365 citations

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation

Andy Peniket, M C Ruiz de Elvira, G. Taghipour et al. · Bone Marrow Transplantation · 2003 · 323 citations

, , +12

Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma

Deborah A. Thomas, Susan O’Brien, Jörge E. Cortes et al. · Blood · 2004 · 246 citations · Full text

Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial

Mathilde Hunault · Blood · 2004 · 237 citations · Full text